Treating SpA Save
Dr. Marina Magrey discusses her takeaways from a session on difficult to manage SpA as well as a study about time to low disease activity for patients previously treated with TNF inhibitors, presented at the 2024 ACR Convergence meeting in Washington, DC.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.